Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 50%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

A Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result after the company paid nearly $5 billion to acquire the drug’s owner.

Private Credit Firm Ninepoint Halts Cash Payouts on Three FundsDeere to Dismiss Some Salaried Workers Amid Farm DownturnMacron Gets Debt Reprimand as S&P Hits France With DowngradeFed Likely to Seek More Evidence Despite Cooler Inflation DataCharting the Global Economy: Europe Inflation Picks Up Before ECB MeetingNigerian Lawmakers Seek to Strip Central Bank of Crucial PowersS. Africa Election Results With 55.

Energy Secretary calls for more nuclear power while celebrating US$35 billion Georgia reactorsThe Daily Chase: GDP comes in softer than expectedThe Daily Chase: Strong numbers from RBC, CIBC cap earnings from big banksCan AI-driven efficiencies address Canada's lagging economic productivity?The Daily Chase: Light trading day on holidays in U.S.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in LAW

Law Law Latest News, Law Law Headlines